Medexus Pharmaceuticals Inc. (TSE:MDP – Get Free Report) shares reached a new 52-week high during trading on Monday . The company traded as high as C$4.19 and last traded at C$4.13, with a volume of 22751 shares traded. The stock had previously closed at C$4.01.
Medexus Pharmaceuticals Stock Up 4.2%
The business has a 50-day moving average price of C$3.92 and a 200-day moving average price of C$3.25. The company has a market capitalization of C$135.01 million, a price-to-earnings ratio of -209.00 and a beta of 0.53.
About Medexus Pharmaceuticals
Medexus is a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions. Medexus’s current focus is on the therapeutic areas of hematology and hematology-oncology and rheumatology and allergy.
Featured Articles
- Five stocks we like better than Medexus Pharmaceuticals
- These 5 Companies Just Made a Massive Bet on Themselves
- 5 Stocks Built to Thrive in a Higher-for-Longer Economy
- RH’s Strong Q1 Still Leaves Investors With One Big Question
- Iran Ceasefire or Not, These 3 Companies Could Win
Receive News & Ratings for Medexus Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medexus Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
